Article information
Full text is only aviable in PDF
BILIOGRAFIA
[1.]
C. Belani, R. Natale, J. Lee.
Randomized phase III trial comparing cisplatin/Ectoposide versus carboplatinu/paclitaxel in advanced et metastatic NSCLC.
Proc Am Soc Clin Oncol, (1998), pp. 455a
[2.]
P.O. Bonomi, D. Finkelstaein, J. Ruckdeschel, et al.
Combination Chemotherapy versus single agents follewed by combination chemotherapy in stage IV non small cell lung cancer: a study of Eastern Cooperative Oncology Group.
J Clinical Oncology, 7 (1989), pp. 1602
[3.]
P. Bononi, K. Kim, A. Chang, et al.
A randomized phase III trial comparing ectoposide+cisplatin versus taxol com cisplatinum in advanced non small cell lung cancer: An Eastern Cooperative Oncology group (ECOG) trial.
Proc Am Soc Clin Oncol, 15 (1996), pp. 382
[4.]
P. Bononi, et al.
Non-small-cell Lung Cancer Chemotherapy.
Lung Cancer/Principles and Practice Lippincott-Raven, 811 (1998),
[5.]
Jeremic Branislav, Yutashibamoto, et al.
Short -term chemotherapy and palliative radiotherapy for elderly patients with stage IV non-small cell lung cancer. A phase II study.
Lung Cancer, 24 (1999), pp. 1-9
[6.]
Bruce E, Johnson MD. Integration of New Agents Into the Treatement of Advanced Non -Small Cell Lung cancer. ASCO 2000 Educacional Book 353-375.
[7.]
Bunn Paul A JR. Karen Kelly. New Combinations in the treatement of Lung cancer: A time for optimism: Chest Abril 2000; vol. 117/number 4 Supplement 1,138 ASCO 2000 Educacional Book. 353-375.
[8.]
P.A. Ellis, I.E. Smith, J.R. Hardy, et al.
Symptom Relief with MVC (mitomycin c, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
Br J Cancer, 71 (1995), pp. 366
[9.]
Fcappuzzo, A Zappala. T Le Chevalier. Should all Stage IV Non-Small Cell Lung Cancer be treated palliatively?.
[10.]
Progress and Perspectives in the Treate Ment of Lung Cancer, Springer, (1999), pp. 183-190
[11.]
V. Fossella Frank.
Second Line Chemotherapy for Non Small Cell Lung Cancer: Lung Cancer, second, (2000), pp. 903
[12.]
F.V. Fossella, D.E. Vore, R. Kerr, et al.
Phase III trial of docetaxel 1000mg/m2 or 75mg/m2 versus Vinorelbinae/ Ifosfamide for Non Small Cell Lung Cancer previously treated with platinum based QT.
Proc Am Soc Clin Oncol, 18 (1999), pp. 460a
[13.]
J.P. Scuuer, T. Berghmans, et al.
Best Suportive Care or Chemotherapy for Stage IV Non Small Cell Lung Cancer: Progress and Perspectives in the Treatement of Lung Cancer, Springer, (1999), pp. 199-208
[14.]
D. Johnson, D. Paul, K. Hande, et al.
Paclitaxel plus Carboplatinum in advanced non-small-cell lung cancer: a phase II trial.
J Clin Oncol, 14 (1996), pp. 2054
[15.]
C. Langer, J. Leighton, R. Comis, et al.
Paclitaxel and Carboplatinum in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity, response, and survival analysis.
J Clin Oncol, 13 (1995), pp. 1860
[16.]
P.G. Lopez, D.J. Stewart.
Chemotherapy in Stage IV (Metastatic) Non Small Cell Lung Cancer.
Cancer Preventions & Control, I (1997), pp. 18-27
[17.]
Nam H. Dang, Roy S. Herbst, et al.
Chemothrerapy of Advanced Non Small Cell Lung Cancer.
Lung Biology in Health and Disease, 140 (2000), pp. 235-271
[18.]
A. Paul, J.R. Bunn, Karen Kelly, et al.
New Combinations in the treatement of Lung Cancer.
Chest, 117 (2000), pp. 138S
[19.]
H. Queiroga.
Estudo dos factores de prognóstico nos estadios avançados do Cancro do Pulmão, (1993),
[20.]
H. Schiller Joan, et al.
Chemotherapy for Advanced Non Small Cell Lung Cancer: Lung Cancer, second edition, (2000), pp. 888
[21.]
F. Shepherd, R. Ramlau, K. Matison.
Randomized study of Taxotere versus best suportive care in mon-small cell lung caric. Patients previousry treated with platinum-based chemotherapy.
Proc Am Soc Clin Oncol, 18 (1999), pp. 463a
[22.]
W. Willem, Huinink Ten Bokker, et al.
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatinum-based chemotherapy in locally advanced or metastatic non small cell lung cancer.
Lung Cancer, 26 (1999), pp. 85-89
[23.]
Yukjo Saitoh, Takehiko Fujisawa, et al.
Prognostic factors in surgical treatment of solitary brain metastasis after resection of non small cell lung cancer: Lung Cancer, (1999), pp. 99-106
[24.]
V. Pinto Espanhol.
Prognóstico do Cancro do Pulmão. Da Clinica à Biologia, (1998), pp. 139-140
Copyright © 2000. Sociedade Portuguesa de Pneumologia/SPP
Recommended
articles
articles
Pulmonol. 2021;27:472-3
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options